Alfred P. Spada
2014
In 2014, Alfred P. Spada earned a total compensation of $795.7K as Executive Vice President, Research and Development, and Chief Scientific Officer at Conatus Pharmaceuticals, a 99% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,372 |
|---|---|
| Option Awards | $385,445 |
| Salary | $325,579 |
| Other | $16,311 |
| Total | $795,707 |
Spada received $385.4K in option awards, accounting for 48% of the total pay in 2014.
Spada also received $68.4K in non-equity incentive plan, $325.6K in salary and $16.3K in other compensation.
Rankings
In 2014, Alfred P. Spada's compensation ranked 8,555th out of 13,032 executives tracked by ExecPay. In other words, Spada earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,555 out of 13,032 | 34th |
Division Manufacturing | 3,178 out of 4,966 | 36th |
Major group Chemicals And Allied Products | 1,077 out of 1,686 | 36th |
Industry group Drugs | 853 out of 1,365 | 38th |
Industry Pharmaceutical Preparations | 661 out of 1,043 | 37th |
Source: SEC filing on April 28, 2016.
Spada's colleagues
We found two more compensation records of executives who worked with Alfred P. Spada at Conatus Pharmaceuticals in 2014.